Effect of risperidone on metabolic parameters in antipsychotic-naïve schizophrenia: A prospective one year follow-up study

Asian Journal of Psychiatry

Volumn 4, Issue 1, 2011, Pages 73-74

  Vinay, H R ^a   Sundar, G S Keerthi ^a   Behere, Rishikesh V ^a   Arasappa, Rashmi ^a   Rao, Naren P ^a   Venkatasubramanian, Ganesan ^a   Sivakumar, P T ^a   Gangadhar, B N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; OLANZAPINE; RISPERIDONE;

CARDIOVASCULAR RISK; EXTRAPYRAMIDAL SYNDROME; FOLLOW UP; HUMAN; LETTER; METABOLIC DISORDER; METABOLIC PARAMETERS; METABOLISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHIZOPHRENIA;

EID: 79952609670     PISSN: 18762018     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajp.2010.09.008     Document Type: Letter

References (10)

1. Assmann G., Nofer J.R. Atheroprotective effects of high-density lipoproteins. Ann. Rev. Med. 2003, 54:321-341.
2. Barrett E., Blonde L., Clement S. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004, 27:596-601.
3. Basu R., Brar J.S., Chengappa K.N., et al. The prevalence of the metabolic syndrome in patients with schizoaffective disorder-bipolar subtype. Bipolar Disord. 2004, 6(4):31-318.
4. Gupta R., Misra A., Vikram N.K., Kondal D., Gupta S.S., Agrawal A., Pandey R.M. Younger age of escalation of cardiovascular risk factors in Asian Indian subjects. BMC Cardiovasc. Disord. 2009, 9:28.
5. Mohan V., Deepa R., Deepa M., Somannavar S., Datta M. A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects. J. Assoc. Physicians India 2005, 53:759-763.
6. Rettenbacher M.A., Ebenbichler C., Hofer A., et al. Early changes of plasma lipids during treatment with atypical antipsychotics. Int. Clin. Psychopharmacol. 2006, 21:369-372.
7. Snehalatha C., Viswanathan V., Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 2003, 26(5):1380-1384.
8. Strassnig M., Miewald J., Keshavan M., Ganguli R. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis. Schizophr. Res. 2007, 93(July (1-3)):90.
9. 2) Asian Indians with normal waist circumference have high cardiovascular risk. Nutrition 2003, 19(6):503-509.
10. Zipursky R.B., Gu H., Green A.I., et al. Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. Br. J. Psychiatry 2005, 187:537-543.